Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Yanaprima Hastapersada Tbk (YPAS) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Yanaprima Hastapersada TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Yanaprima Hastapersada Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Yanaprima Hastapersada Tbk trades at Rp600 (market cap 397.46B, 16.1K 24h volume). The key difference: Yanaprima Hastapersada Tbk is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 16.1K). Which is the better fit depends on your goals.

DGNSYPAS
Market Cap
310.75B397.46B
Volume
963.6K16.1K
Lot
9.64K161
Turnover
217.67M9.82M
Average Price
225.89609.91
Value
217.67M9.82M
Indicative Equilibrium Price
226600
Indicative Equilibrium Volume
1K3

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
YPAS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Yanaprima Hastapersada Tbk

PT Yanaprima Hastapersada Tbk (the Company) was established in Indonesia based on Notarial Deed No. 38 of Emmy Hartati Yunizar, S.H., dated December 14, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 5 of Marina Soewana, S.H., dated Nov 1, 2007, concerning among others, the change of capital stucture, Company name and public offering.

Read more on YPAS